Brian Fahie, Ph.D. is Senior Director, Analytical Science R&D, at Eli Lilly responsible for Lilly’s global analytical efforts supporting small molecule active pharmaceutical ingredient (API) development. Dr. Fahie is well respected for building world class organizations, differentiating between strategic capabilities and needed capacity. A proven leader at creating environments where his staff can excel, Dr. Fahie is a prolific speaker on career development and advancement. Prior to his current assignment, Dr. Fahie held leadership roles in bioproduct development at Lilly. Previous to joining Lilly, Dr. Fahie held leadership positions at Glaxo and Glaxo Wellcome.